XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ 25,530,961 $ (2,625,881)
Adjustments to reconcile net income (loss) to net cash flows used in operating activities:    
Depreciation and amortization 822,489 250,156
Stock based compensation 1,605,949 1,462,270
Issuance of common stock for services 30,700
Amortization of debt discount 86,867
Provision for doubtful accounts receivable 9,990
Interest paid through issuance of common stock 99,945
Gain on extinguishment of debt (10,000) (1,417,413)
Secured convertible debentures issuance expense 34,906
Change in fair value of secured convertible debentures 1,300,252
Change in fair value of proceeds investment agreement (5,250,000)
Change in fair value of contingent consideration promissory notes and earn-out agreements (3,732,789)
Change in fair value of warrant derivative liability (36,664,907)
Warrant modification expense 295,780
Provision for inventory obsolescence 1,954,738 275,690
Increase (decrease) in:    
Accounts receivable – trade (29,838) (634,443)
Accounts receivable – other (including related party) (693,992) (1,015,191)
Inventories (1,431,080) (3,197,552)
Prepaid expenses (3,839,458) (1,649,603)
Income tax refund receivable 44,650
Operating lease right of use assets 180,497 (630,716)
Other assets (738,466) 177,619
Accounts payable (1,907,608) (1,195,310)
Accrued expenses 166,874 (41,274)
Income taxes payable (5,331) 1,224
Operating lease obligations (195,884) 633,136
Contract liabilities 856,967 (14,747)
Net cash used in operating activities (17,825,108) (13,274,715)
Cash Flows from Investing Activities:    
Purchases of property, plant and equipment (6,428,225) (621,860)
Additions to intangible assets (1,189,132) (77,329)
Cash paid for acquisition of Medical Billing Company (1,026,508)
Cash paid for acquisition of Medical Billing Company (2,270,000)
Cash paid for acquisition of TicketSmarter (8,615,514)
Repayment (issuance) of notes receivable 405,000 (800,000)
Net cash used in investing activities (19,124,379) (1,499,189)
Cash Flows from Financing Activities:    
Proceeds from issuance of common stock upon exercise of pre-funded warrants 53,224,000
Net proceeds from sale of common stock in registered direct offerings 13,346,600
Repurchase and cancellation of common stock (1,975,079)
Proceeds from unsecured promissory note payable, related party 319,000
Proceeds from unsecured promissory note payable 100,000
Proceeds from PPP/EIDL Loans 1,568,900
Repayment of proceeds investment agreement (1,250,000)
Proceeds from issuance of common stock and warrants, net of issuance costs 12,829,241
Proceeds from secured convertible debentures 1,500,000
Secured convertible debenture issuance expense (34,906)
Principal payments on related party note payable (319,000)
Principal payment on unsecured notes payable (400,000)
Principal payment on secured convertible debentures (748,180)
Proceeds from issuance of common stock upon exercise of warrants 5,203,122
Proceeds from exercising stock options 7,800
Net cash provided by financing activities 64,595,521 18,775,977
Net increase in cash and cash equivalents 27,646,034 4,002,073
Cash, cash equivalents, beginning of year 4,361,758 359,685
Cash, cash equivalents, end of year 32,007,792 4,361,758
Supplemental disclosures of cash flow information:    
Cash payments for interest 128,911
Cash payments for income taxes 1,224 4,776
Supplemental disclosures of non-cash investing and financing activities:    
Restricted common stock grant 856 846
Restricted common stock forfeitures 8 37
Amounts allocated to common stock purchase warrants in connection with proceeds from secured convertible debentures 741,947
Issuance of common stock upon conversion of secured convertible notes 2,924,740
Issuance of contingent consideration earn-out agreement for business acquisitions 3,700,000
Issuance of contingent consideration promissory note for business acquisitions 1,000,000
Assets acquired in business acquisitions 6,324,189
Identifiable intangible assets acquired in business acquisitions 6,800,000
Goodwill acquired in business acquisitions 9,931,547
Liabilities assumed in business acquisitions 5,453,353
Common stock issued as consideration for business acquisitions 990,360
Amounts allocated to initial measurement of warrant derivative liabilities in connection to the warrants and pre-funded warrants 51,216,058
Cancellation of treasury stock $ 2,157,225